MRMD Marimed Inc

  1. Stocks
  2. Healthcare
  3. OTC: MRMD

Price (delayed)

$0.3

Market cap

$98.74M

P/E Ratio

6

Dividend/share

N/A

EPS

$0.05

Enterprise value

$105.29M

Highlights
The gross profit has surged by 185% year-on-year and by 33% since the previous quarter
The revenue has soared by 172% YoY and by 34% from the previous quarter
The quick ratio has contracted by 6% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: RADCQ

Key stats

What are the main financial stats of MRMD
Market
Shares outstanding
329.14M
Market cap
$98.74M
Enterprise value
$105.29M
Valuations
Price to earnings (P/E)
6
Price to book (P/B)
3.82
Price to sales (P/S)
1.07
EV/EBIT
3.45
EV/EBITDA
3.2
EV/Sales
1.16
Earnings
Revenue
$91.03M
EBIT
$30.5M
EBITDA
$32.92M
Free cash flow
$10.49M
Per share
EPS
$0.05
Free cash flow per share
$0.03
Book value per share
$0.08
Revenue per share
$0.28
TBVPS
$0.31
Balance sheet
Total assets
$102.87M
Total liabilities
$40.38M
Debt
$23.91M
Equity
$25.34M
Working capital
$20.87M
Liquidity
Debt to equity
0.94
Current ratio
2.11
Quick ratio
1.51
Net debt/EBITDA
0.2
Margins
EBITDA margin
36.2%
Gross margin
58.1%
Net margin
19.2%
Operating margin
33.5%
Efficiency
Return on assets
20.5%
Return on equity
140%
Return on invested capital
34.7%
Return on capital employed
36.3%
Return on sales
33.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MRMD stock price

How has the Marimed stock price performed over time
Intraday
0%
1 week
11.11%
1 month
26.32%
1 year
-21.05%
YTD
9.17%
QTD
13.59%

Financial performance

How have Marimed's revenue and profit performed over time
Revenue
$91.03M
Gross profit
$52.89M
Operating income
$30.48M
Net income
$17.49M
Gross margin
58.1%
Net margin
19.2%
The gross profit has surged by 185% year-on-year and by 33% since the previous quarter
The revenue has soared by 172% YoY and by 34% from the previous quarter
MRMD's operating income has soared by 170% YoY and by 48% QoQ
Marimed's operating margin has surged by 126% YoY and by 11% QoQ

Growth

What is Marimed's growth rate over time

Valuation

What is Marimed stock price valuation
P/E
6
P/B
3.82
P/S
1.07
EV/EBIT
3.45
EV/EBITDA
3.2
EV/Sales
1.16
The company's EPS has surged by 112% YoY and by 67% QoQ
MRMD's P/B is 86% below its last 4 quarters average of 27.7
The company's equity has surged by 66% QoQ
The revenue has soared by 172% YoY and by 34% from the previous quarter
The P/S is 61% lower than the last 4 quarters average of 2.7

Efficiency

How efficient is Marimed business performance
MRMD's return on invested capital has surged by 140% year-on-year and by 43% since the previous quarter
The ROE has soared by 130% year-on-year but it has declined by 17% since the previous quarter
Marimed's ROA has soared by 119% YoY and by 78% from the previous quarter
The company's return on sales has surged by 115% YoY and by 10% QoQ

Dividends

What is MRMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MRMD.

Financial health

How did Marimed financials performed over time
MRMD's total assets is 155% higher than its total liabilities
MRMD's total assets has soared by 52% YoY and by 14% QoQ
Marimed's total liabilities has decreased by 30% YoY but it has increased by 8% QoQ
Marimed's debt is 6% less than its equity
Marimed's debt to equity has surged by 108% YoY but it has decreased by 44% QoQ
The company's equity has surged by 66% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.